Učitavanje...
Augmentation of radiation response by motesanib, a multikinase inhibitor that targets vascular endothelial growth factor receptors
BACKGROUND: Motesanib is a potent inhibitor of VEGFR1, 2 and 3, PDGFR and Kit receptors. In this report we examine the interaction between motesanib and radiation in vitro and in head and neck squamous cell carcinoma (HNSCC) xenograft models. EXPERIMENTAL DESIGN: In vitro assays were performed to as...
Spremljeno u:
Glavni autori: | , , , , , , , , , |
---|---|
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
2010
|
Teme: | |
Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3216115/ https://ncbi.nlm.nih.gov/pubmed/20507929 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-3385 |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|